Skip to main content
Equibles

Invesco Ltd.

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 914208 Atlanta, GA
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,791,337
+$3,484,953 QoQ
Shares Held
264,389
+704.2% QoQ
Ownership
0.445%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 158 holders
Holding Since
Jun 2021
16 quarters on record
Voting authority Sole 0% Shared 99% None 1%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. ZVRA ranks #92 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in ZVRA

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,791,337 264,389
2026-03-31 $306,384 32,874
2025-12-31 $288,350 32,182
2025-09-30 $299,896 31,535
2025-06-30 $173,944 19,744
2025-03-31 $142,474 19,022
2024-12-31 $153,321 18,384
2024-09-30 $106,715 15,377
2024-06-30 $76,595 15,632
2024-03-31 $92,329 15,919
2023-12-31 $108,100 16,504
2023-09-30 $64,447 13,371
2023-06-30 $68,192 13,371
2022-03-31 $51,345 10,208
2021-09-30 $136,627 14,644
2021-06-30 $145,250 11,330